Results 141 to 150 of about 832,161 (339)

Analysis of a fetal calf serum-induced T cell line. I. H-2 restricted growth and expression of membrane-bound and released molecules bearing 5936-idiotypic determinants. [PDF]

, 1981
Marie Suzan, Alain Bourgois, Annie Boned, C. de Préval, Pierre Golstein, B Y Rubin   +5 more
openalex   +1 more source

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

Molecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza, David James, Emma Creagh, James T. Murray   +3 more
wiley   +1 more source

The serotonin reuptake inhibitor fluoxetine induces human fetal membrane sterile inflammation through p38 MAPK activation. [PDF]

J Reprod Immunol, 2023
Fabrizio VA, Lindsay CV, Wilcox M, Hong S, Lynn T, Norwitz ER, Yonkers KA, Abrahams VM.   +7 more
europepmc   +1 more source

Prolonged rupture of the fetal membranes and neonatal outcome [PDF]

, 1989
I G Verber, J. Malcolm Pearce, L New, Patricia Hamilton, E. Graham Davies   +4 more
openalex   +1 more source

Neurologic phenotype of Schimke immuno-osseous dysplasia and neurodevelopmental expression of SMARCAL1

, 2008
Schimke immuno-osseous dysplasia (OMIM 242900) is an uncommon autosomal-recessive multisystem disease caused by mutations in SMARCAL1 (swi/snf-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1), a gene encoding a ...
Armstrong, D.L., Boerkoel, C.F., Choi, K., Clewing, J.M., Deguchi, K., Elizondo, L.I., Fujita, Y., Hirano, R., Huang, C., Inoue, K., Kanemura, Y., Lou, S., Lucke, T., Marwedel, K.M., Northrop, J., Okano, H., Powell, R., SantaCruz, K., Sloan, E.A., van der Kooy, D., Willaime-Morawek, S.   +20 more
core   +1 more source

Olaparib synergy screen reveals Exemestane induces replication stress in triple‐negative breast cancer

Molecular Oncology, EarlyView.
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh, Liping Su, Suet Lin Chia, Xiaohe Tian, Haslina Ahmad, Martin R. Gill   +5 more
wiley   +1 more source

Site variability in the solubility of collagen of human fetal membranes [PDF]

, 1986
N.S. Al‐Zaid, K.A. Gumaa, M.N. Bou-Resli, Mariam Ibrahim   +3 more
openalex   +1 more source

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

Molecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou, Zhen Wang, Fei Yang, Xiao Han, Lei Li, Huadong Liu   +5 more
wiley   +1 more source

Calcium, Potassium, Sodium, and Magnesium Concentrations in the Placenta, Umbilical Cord, and Fetal Membrane from Women with Multiple Pregnancies. [PDF]

Life (Basel), 2023
Grzeszczak K, Kapczuk P, Kupnicka P, Cecerska-Heryć E, Kwiatkowski S, Chlubek D, Kosik-Bogacka D.   +6 more
europepmc   +1 more source

Fetal Body and Breathing Movements as Predictors of Intraamniotic Infection in Preterm Premature Rupture of Membranes [PDF]

, 1988

openalex   +1 more source